Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1128/IAI.00348-19

http://scihub22266oqcxt.onion/10.1128/IAI.00348-19
suck pdf from google scholar
31085710!6652762!31085710
unlimited free pdf from europmc31085710    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid31085710      Infect+Immun 2019 ; 87 (8): ?
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Spectrum of Trained Innate Immunity Induced by Low-Virulence Candida Species against Lethal Polymicrobial Intra-abdominal Infection #MMPMID31085710
  • Lilly EA; Yano J; Esher SK; Hardie E; Fidel PL Jr; Noverr MC
  • Infect Immun 2019[Aug]; 87 (8): ? PMID31085710show ga
  • Polymicrobial intra-abdominal infections (IAI) are clinically prevalent and cause significant morbidity and mortality, especially those involving fungi. Our laboratory developed a mouse model of polymicrobial IAI and demonstrated that coinfection with Candida albicans and Staphylococcus aureus (C. albicans/S. aureus) results in 80 to 90% mortality in 48 to 72 h due to robust local and systemic inflammation. Surprisingly, inoculation with Candida dubliniensis and S. aureus resulted in minimal mortality, and rechallenge of mice with lethal C. albicans/S. aureus conferred >90% protection up to 60 days postinoculation. Protection was mediated by Gr-1(+) polymorphonuclear leukocytes, indicating a novel form of trained innate immunity (TII). The purpose of this study was to determine the microbial requirements and spectrum of innate-mediated protection. In addition to Candida dubliniensis, several other low-virulence Candida species (C. glabrata, C. auris, and C. albicansefg1Delta/Delta cph1Delta/Delta) and Saccharomyces cerevisiae conferred significant protection with or without S. aureus For C. dubliniensis-mediated protection, hyphal formation was not required, with protection conferred as early as 7 days after primary challenge but not at 120 days, and also following multiple lethal C. albicans/S. aureus rechallenges. This protection also extended to a lethal intravenous (i.v.) C. albicans challenge but had no effect in the C. albicans vaginitis model. Finally, studies revealed the ability of the low-virulence Candida species that conferred protection to invade the bone marrow by 24 h post-primary challenge, with a positive correlation between femoral bone marrow fungal infiltration at 48 h and protection upon rechallenge. These results support and further extend the characterization of this novel TII in protection against lethal fungal-bacterial IAI and sepsis.
  • |*Immunity, Innate[MESH]
  • |Animals[MESH]
  • |Bone Marrow/microbiology[MESH]
  • |Candida/*physiology[MESH]
  • |Coinfection/*immunology/prevention & control[MESH]
  • |Female[MESH]
  • |Hyphae/physiology[MESH]
  • |Mice[MESH]
  • |Myeloid-Derived Suppressor Cells/physiology[MESH]
  • |Staphylococcus aureus/physiology[MESH]
  • |Time Factors[MESH]
  • |Vagina/microbiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box